Abstract:The vascular endothelial growth factor receptor-2 kinases (VEGFR-2) expressed on tumor cells and vessels are attractive targets for cancer treatment. Potent inhibitors for the VEGFR-2 receptor are novel strategies to develop anti-cancer drugs. In this work, template ligand-based 3D-QSAR studies were performed on a series of benzoxazole derivatives toward different cell lines (HepG2, HCT-116 and MCF-7). Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques were used to generate 3D-QSAR models. Good predictability was derived for the optimal CoMFA models (HepG2: R-cv(2) = 0.509, R-pred(2) = 0.5128; HCT-116: R-cv(2) = 0.574, R-pred(2) = 0.5597; MCF-7: R-cv(2) = 0.568, R-pred(2) = 0.5057) and CoMSIA models (HepG2: R-cv(2) = 0.711, R-pred(2) = 0.6198; HCT-116: R-cv(2) = 0.531, R-pred(2) = 0.5804; MCF-7: R-cv(2) = 0.669, R-pred(2) = 0.6577). In addition, the contour maps derived from CoMFA and CoMSIA models were also generated to illustrate the relationship between different fields and the inhibitory activities. Moreover, molecular docking and molecular dynamics (MD) simulations were also conducted to understand the binding modes and the potential interactions between the receptor and the inhibitors. Some key residues (Leu35, Val43, Lys63, Leu84, Gly117, Leu180 and Asp191) were pointed out for stabilizing the inhibitors in the binding pocket. The binding free energies for the inhibitors agreed well with the experimental inhibitory activity and indicated that steric, electrostatic and hydrogen bond interactions are the main driving force for inhibitor-receptor binding. Overall, a good consistency between theoretical 3D-SQAR and molecular docking and MD simulation studies would provide directions for the design of new candidates, avoiding time-consuming and costly synthesis and biological evaluations. On the whole, the results derived from this study could expand the understanding of benzoxazole derivatives as anticancer agents and would be of great help in lead optimization for early drug discovery of highly potent anticancer activity targeting VEGFR-2.

2D and 3D‐QSAR Studies on Antiproliferative Thiazolidine Analogs

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

2D/3D-QSAR STUDY ON ANALOGUES OF 2-METHOXYESTRADIOL WITH ANTICANCER ACTIVITY

2D/3d-Qsar Studies of [1,2,4]Triazolo[1,5-A]pridinylpyridine Derivatives As Potent Anticancer Agents

A QSAR Study and Molecular Design of Benzothiazole Derivatives As Potent Anticancer Agents

3D-Qsar of Benzothiazole Derivatives As Potent Anticancer Agents

QSAR Studies and Molecular Design of Phenanthrene‐based Tylophorine Derivatives with Anticancer Activity

3D-QSAR Study on a Series of Indolo[1,2-b]quinazoline Derivatives with Anticancer Activity and Their Molecular Design

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

QSAR Studies on a Series of 7,8-Dialkyl-1,3-diaminopyrrolo-[3,2-f]quinazolines with Anticancer Activity

Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.

Synthesis, DNA Intercalation and 3D QSAR Analysis of Cis-2,4,5-trisubstituted-1,3-dithiolanes As a Novel Class of Antitumor Agents.

<i>In silico</i> studies of a novel scaffold of benzoxazole derivatives as anticancer agents by 3D-QSAR, molecular docking and molecular dynamics simulations

3d-Qsar And Molecular Docking Studies On Benzotriazoles As Antiproliferative Agents And Histone Deacetylase Inhibitors

DFT and 3D-QSAR Studies of Anti-Cancer Agents M-(4-morpholinoquinazolin-2-yl) Benzamide Derivatives for Novel Compounds Design

Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity

Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

3D-QSAR Study of 7,8-Dialkyl-1,3-diaminopyrrolo-[3,2-f] Quinazolines with Anticancer Activity As DHFR Inhibitors

Molecular modelling of antiproliferative inhibitors based on SMILES descriptors using Monte-Carlo method, docking, MD simulations and ADME/Tox studies

Structure–activity Relationship and Antitumor Activity of Thio-Benzodiazepines As P53–mdm2 Protein–protein Interaction Inhibitors